IMMUNEONCO-B (01541) Redeems HK$205 Million Shenwan Products and Subscribes to HK$212 Million Shenwan Hongyuan Wealth Management Products

Stock News

05/22

IMMUNEONCO-B (01541) announced that on May 22, 2026, the company notified Shenwan Hongyuan Securities (Hong Kong) to redeem, in cash, Shenwan products totaling HK$205 million, which constituted all Shenwan products held by the company at that time. The estimated income from this redemption is approximately HK$4.969 million, representing unaudited interest income generated from the redemption transaction. Following the redemption, the group will no longer hold any outstanding wealth management products issued by Shenwan Hongyuan Securities (Hong Kong). Additionally, on May 22, 2026, the company agreed to subscribe to wealth management products from Shenwan Hongyuan Securities (Hong Kong) with a total value of HK$212 million. This subscription is funded by the group's internal surplus cash reserves.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1186724819"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1186724819\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1186724819?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-22 21:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1186724819","market":"hk","top_or_hot":-1,"title":"IMMUNEONCO-B (01541) Redeems HK$205 Million Shenwan Products and Subscribes to HK$212 Million Shenwan Hongyuan Wealth Management Products","media":"Stock News","content":"<p>IMMUNEONCO-B (01541) announced that on May 22, 2026, the company notified Shenwan Hongyuan Securities (Hong Kong) to redeem, in cash, Shenwan products totaling HK$205 million, which constituted all Shenwan products held by the company at that time. The estimated income from this redemption is approximately HK$4.969 million, representing unaudited interest income generated from the redemption transaction. Following the redemption, the group will no longer hold any outstanding wealth management products issued by Shenwan Hongyuan Securities (Hong Kong). Additionally, on May 22, 2026, the company agreed to subscribe to wealth management products from Shenwan Hongyuan Securities (Hong Kong) with a total value of HK$212 million. This subscription is funded by the group's internal surplus cash reserves.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IMMUNEONCO-B (01541) Redeems HK$205 Million Shenwan Products and Subscribes to HK$212 Million Shenwan Hongyuan Wealth Management Products</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIMMUNEONCO-B (01541) Redeems HK$205 Million Shenwan Products and Subscribes to HK$212 Million Shenwan Hongyuan Wealth Management Products\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-05-22 21:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>IMMUNEONCO-B (01541) announced that on May 22, 2026, the company notified Shenwan Hongyuan Securities (Hong Kong) to redeem, in cash, Shenwan products totaling HK$205 million, which constituted all Shenwan products held by the company at that time. The estimated income from this redemption is approximately HK$4.969 million, representing unaudited interest income generated from the redemption transaction. Following the redemption, the group will no longer hold any outstanding wealth management products issued by Shenwan Hongyuan Securities (Hong Kong). Additionally, on May 22, 2026, the company agreed to subscribe to wealth management products from Shenwan Hongyuan Securities (Hong Kong) with a total value of HK$212 million. This subscription is funded by the group's internal surplus cash reserves.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1564","symbol_name":"中资券商股","start_time":0,"source_url":"","article_id":"1186724819","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1186724819","pubTimestamp":1779456509,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"IMMUNEONCO-B (01541) announced that on May 22, 2026, the company notified Shenwan Hongyuan Securities (Hong Kong) to redeem, in cash, Shenwan products totaling HK$205 million, which constituted all...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1564":"中资券商股","01541":"宜明昂科-B","BK0028":"国家队","BK0012":"证金概念","BK0276":"资本市场","BK0183":"MSCI概念","BK0188":"融资融券","BK1161":"生物科技","000166":"申万宏源","BK1147":"投资银行业与经纪业","06806":"申万宏源"},"translate_title":"IMMUNEONCO-B(01541)赎回2.05亿港元申万产品及认购2.12亿港元申万宏源理财产品","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06806":1,"000166":1,"01541":1},"content_text":"IMMUNEONCO-B (01541) announced that on May 22, 2026, the company notified Shenwan Hongyuan Securities (Hong Kong) to redeem, in cash, Shenwan products totaling HK$205 million, which constituted all Shenwan products held by the company at that time. The estimated income from this redemption is approximately HK$4.969 million, representing unaudited interest income generated from the redemption transaction. Following the redemption, the group will no longer hold any outstanding wealth management products issued by Shenwan Hongyuan Securities (Hong Kong). Additionally, on May 22, 2026, the company agreed to subscribe to wealth management products from Shenwan Hongyuan Securities (Hong Kong) with a total value of HK$212 million. This subscription is funded by the group's internal surplus cash reserves.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}